Phase I/II study of oxaliplatin (L-OHP) plus 5-Fluorouracil concurrent with external beam radiotherapy (EBRT) in rectosigmoid carcinoma

被引：0
|
作者：
Cajal, TRY [1 ]
Rayo, SG [1 ]
Calvo, E [1 ]
Aristu, JJ [1 ]
Villafranca, E [1 ]
Cañón, R [1 ]
Moreno, M [1 ]
Hernández, JL [1 ]
Azinovic, I [1 ]
机构：
[1] Clin Univ, Dept Oncol, Pamplona 31008, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
239
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [41] A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    C Garufi
    E Bria
    B Vanni
    A M R Zappalà
    I Sperduti
    E Terzoli
    British Journal of Cancer, 2003, 89 : 1870 - 1875
  • [42] A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    Garufi, C
    Bria, E
    Vanni, B
    Zappalà, AMR
    Sperduti, I
    Terzoli, E
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1870 - 1875
  • [43] Concomitant radiotherapy with protracted 5-fluorouracil infusion in locally advanced carcinoma of the pancreas:: A phase II study
    Osti, MF
    Costa, AM
    Bianciardi, F
    De Nicolò, M
    Donato, V
    Silecchia, G
    Enrici, RM
    TUMORI JOURNAL, 2001, 87 (06): : 398 - 401
  • [44] A phase I/II study of cetuximab in combination with 5-fluorouracil (5-FU)/folinic acid (FA) plus weekly oxaliplatin (L-OHP) (FUFOX) in the first-line treatment of patients with metastatic colorectal cancer (mCRC) expressing epidermal growth factor receptor (EGFR). Preliminary results.
    Seufferlein, T
    Dittrich, C
    Riemann, J
    Woell, E
    Herrmann, T
    Lordick, F
    Arnold, D
    Olchowka, K
    Hoehler, T
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 281S - 281S
  • [45] A phase I/II study of preoperative oxaliplatin (0), 5-fluorouracil (5-FU), and external beam radiation therapy (XRT) in locally advanced rectal cancer: CALGB 89901.
    Ryan, DP
    Niedzwiecki, D
    Hollis, D
    Miedema, BE
    Wadler, S
    Tepper, JE
    Mayer, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 260S - 260S
  • [46] Phase I study of docetaxel (TXT) and 5-fluorouracil (5-FU) with concurrent radiotherapy in patients with advanced esophageal cancer
    Hihara, Jun
    Yoshida, Kazuhiro
    Hamai, Yoichi
    Emi, Manabu
    Yamaguchi, Yoshiyuki
    Wadasaki, Koichi
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2597 - 2603
  • [47] Combined radiotherapy, 5-Fluorouracil (5FU) continuous infusion and weekly Oxaliplatin in advanced rectal cancer: Phase I study
    Francois, Eric D.
    Ychou, Marc
    Ducreux, Michel
    Bertheault-Cvitkovic, Frederique
    Giovannini, Marc
    Conroy, Thierry
    Lemansk, Claire
    Thomas, Oliver
    Mari, Veronique
    ANNALS OF ONCOLOGY, 2004, 15 : 96 - 97
  • [48] TIMED-FLAT-INFUSION (TFI) OF 5-FLUOROURACIL (5-FU) PLUS WEEKLY ALTERNATING IRINOTECAN (CPT-11) AND OXALIPLATIN (L-OHP) IN ADVANCED COLORECTAL CANCER: PRELIMINARY RESULTS OF A DOSE-FINDING STUDY
    Morelli, M. F.
    Ricevuto, E.
    Calista, F.
    Gugliemi, F.
    Cannita, K.
    Rispoli, A. I.
    Santomaggio, A.
    Porzio, G.
    Lanfiuti, P.
    Mancini, M.
    Marchetti, P.
    Ficorella, C.
    ANNALS OF ONCOLOGY, 2004, 15 : 64 - 64
  • [49] Randomized Phase II Study of Gemcitabine Plus Radiotherapy Versus Gemcitabine, 5-Fluorouracil, and Cisplatin Followed by Radiotherapy and 5-Fluorouracil for Patients With Locally Advanced, Potentially Resectable Pancreatic Adenocarcinoma
    Landry, Jerome
    Catalano, Paul J.
    Staley, Charles
    Harris, Wayne
    Hoffman, John
    Talamonti, Mark
    Xu, Natalie
    Cooper, Harry
    Benson, Al B., III
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (07) : 587 - 592
  • [50] Weekly Chemotherapy of 5-Fluorouracil Plus Cisplatin Concurrent with Radiotherapy for Esophageal Cancer Patients with Postoperative Locoregional Recurrence: Results from a Phase II Study
    Chen, B.
    Li, Q.
    Li, Q.
    Hu, Y.
    Liu, M.
    Zhu, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S127 - S128
12345